The Next Generation of Consumer Healthcare Leaders: Why Private Equity's Talent Playbook May Be Changing

Success in consumer healthcare private equity has been driven by identifying the right assets, but in an increasingly competitive market, the delivery of value creation strategies critically depends on identifying the right leaders.

As investment activity accelerates, ownership structures become more sophisticated, and sponsors prepare for a new wave of exits, executive talent is emerging as one of the most important drivers of enterprise value. But one important question remains largely unexplored:

Where are tomorrow's consumer healthcare leaders coming from?

For much of the past decade, private equity investors have overwhelmingly prioritized deep sector expertise over prior sponsor-backed experience when building leadership teams. The prevailing belief was that executives who understood consumer healthcare could learn private equity faster than private equity executives could learn consumer healthcare.

That philosophy helped build one of the most attractive sectors in healthcare investing, but now, the market is changing and the profile of the leaders required to create value may be changing along with it.

The Market Is Entering a New Phase

Consumer healthcare is entering one of its most active periods in recent memory.

According to Bain & Company's Global Healthcare Private Equity Report, global healthcare private equity deal value reached $115 billion in 2024, making it the second-highest year on record. Five healthcare transactions exceeded $5 billion, reflecting renewed investor confidence and larger platform investments.

Bain also notes that healthcare private equity exit volume remains 41% below its 2021 peak, placing increased pressure on sponsors to maximize enterprise value before bringing portfolio companies back to market.

At the same time, ownership structures themselves are evolving. Jefferies reports that continuation vehicles represented approximately 14% of sponsor-backed exits, while nearly 80% of the world's 100 largest private equity firms have completed at least one continuation vehicle transaction. More than ever, leadership teams are expected to create value across multiple ownership cycles rather than a single investment horizon.

Consumer healthcare also remains a key area of dealmaker focus. PwC's 2025 Global M&A Trends in Health Industries
identified consumer healthcare as one of the expected M&A hotspots in health industries, alongside biotech, portfolio optimization, GLP-1s, telehealth, healthtech, and health analytics.

Why Leadership Is Becoming a Source of Alpha

Investment theses are becoming more complex, commercial growth is harder to achieve organically, and management teams are expected to deliver measurable performance improvements much earlier in the investment lifecycle. As financial engineering becomes less differentiated, leadership execution is becoming a source of alpha.

Sponsors are looking for executives who can accelerate commercial performance, navigate organizational transformation, professionalize operations, and position businesses for successful exits, all while creating measurable enterprise value across ownership structures.

That raises the stakes for leadership selection in ways the market has yet to fully examine.

The next scarcity in consumer healthcare private equity may not be capital – it may be leadership.

The Leadership Model That Built Consumer Healthcare

Historically, sponsors have looked to hire the industry's best operators, not necessarily its most experienced private equity executives.

Many of today's CEOs, CFOs, and COOs leading sponsor-backed consumer healthcare businesses built their careers inside organizations such as Haleon, Reckitt, Kenvue, Bayer Consumer Health, Nestlé Health Science, Procter & Gamble, and Colgate-Palmolive before entering private equity for the first time. These organizations became the sector's unofficial executive development academies.

Sponsors valued executives who understood regulatory complexity, omnichannel commercialization, innovation, manufacturing, retailer dynamics, and global brand management. Sponsor-backed experience was often viewed as additive rather than essential – an approach that largely worked.

Now, it raises one of the biggest unanswered talent questions in consumer healthcare: What percentage of today's CEOs, CFOs, and COOs are leading a PE-backed company for the first time?

The Next Talent Constraint

The next chapter of consumer healthcare investing may expose a different kind of scarcity – not capital, but leadership.

As more assets approach exit, sponsors are searching for executives who can do more than run successful businesses. They need leaders who understand how enterprise value is created and sustained inside a sponsor-backed environment, such as those who have successfully navigated:

• Corporate carve outs
• Operational transformation
• Commercial acceleration
• M&A integration
• Active board governance
• Multiple ownership transitions
• Exit readiness

Those capabilities are rarely developed through traditional corporate career paths alone.

If many of today's executives entered private equity-backed companies for the first time in their current roles, as we believe may be the case, the industry could soon encounter a meaningful leadership bottleneck. The number of executives who combine deep consumer healthcare expertise with proven sponsor-backed operating experience may simply not keep pace with demand.

Looking Beyond the Resume

The more interesting question isn't whether executives have private equity experience. It's where the market is sourcing its leaders.

• Are a handful of multinational organizations producing the overwhelming majority of PE-ready leaders?
• Are sponsors repeatedly hiring from the same executive ecosystems?
• Do executives from consumer brands outperform those coming from pharmaceuticals, medtech, or healthcare services?

Perhaps most importantly: What happens when ownership changes?

• Who stays?
• Who leaves?
• Which executive roles are most commonly replaced?
• Are incoming CEOs and CFOs recruited from other sponsor-backed businesses, or are investors continuing to bet on first-time private equity operators?

Understanding those patterns may reveal what investors truly value in leadership. They may also reveal whether the industry's long-standing talent playbook is beginning to change.

A U.S. vs. Europe Story

There is also an opportunity to better understand how hiring philosophies differ across markets.

While approaches vary by firm, European sponsors have often placed greater emphasis on deep sector expertise, whereas U.S. investors have generally shown a greater willingness to prioritize executives with prior sponsor-backed experience.

As ownership cycles become more sophisticated and value creation timelines continue to compress, those philosophies may begin to converge.

The firms that outperform may ultimately be those capable of identifying executives who combine category expertise with the pace, governance, and commercial rigor required inside sponsor-backed businesses.

Looking Ahead

Consumer healthcare has been built by exceptional industry operators. The next phase of value creation may depend on a new generation of leaders who combine deep sector expertise with the ability to create measurable enterprise value inside sponsor-backed businesses.

For investors, operating partners, and portfolio company boards, understanding where that next generation of leadership will come from may prove to be one of the defining talent and investment questions of the decade.